Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: A comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 1, 2009, Pages 82-87

  Sabino, Adriano ^a   Fernandes, Ana Paula ^a   Lima, Luciana Moreira ^a   Ribeiro, Daniel Dias ^a   Sousa, Marinez Oliveira ^a   Castro Santos, Maria Elizabeth Rennó ^b   Mota, Ana Paula Lucas ^a   Dusse, Luci Maria Sant'Ana ^a   Gračas Carvalho, Maria ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa de Belo Horizonte   (Brazil)

Author keywords

Coronary arterial disease and peripheral arterial obstructive disease; Homocysteine; Ischemic stroke; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CHOLESTEROL; CYTOSINE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; THREONINE;

ADULT; AGE; AGED; ARTERY THROMBOSIS; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AMINO ACID SUBSTITUTION; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; BRAZIL; COMORBIDITY; CORONARY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION, MISSENSE; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 60649093092     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0172-z     Document Type: Article

References (37)

1. Ross R (1999) Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126
2. Libby P, Simon DI (2001) Inflammation and thrombosis: The clot thickens. Circulation 103:1718-1720
3. Luscher TF, Creager MA, Beckman JA, Cosentino F (2003) Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 108:1655-1661
4. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241
5. Libby P (1998) Atherosclerosis. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds). Harrison's principles of internal medicine, 14th edn. McGraw-Hill, New York
6. Nguyen VHD, Mclaughlin MA (2002) Coronary artery disease in women: A review of emerging cardiovascular risk factors. Mt Sinai J Med 69:338-349
7. Jeffrey T, Lu AB, Mark A, Creager MD (2004) The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med 5:189-193
8. World Health Report (2002) Reducing risks, promoting healthy life. World Health Organization, Geneva, Switzerland. http://www.who.int/whr/2002. Cited 30 Aug 2007
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 360:1903-1913
10. Takaishi H, Taniguchi T, Fujioka Y, Ishikawa Y, Yokoyama M (2004) Impact of increasing diabetes on artery coronary disease in the past decade. J Atheroscler Thromb 11:271-277
11. Troiano RP, Flegal KM, Kukzmarski RJ, Campbell SM, Johnson CL (1995) Overweight prevalence and trends for children and adolescents - the National and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 149:1085-1091
12. Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA (2003). Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 89:993-997
13. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993). Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 39:1764-1779
14. Frosst P, Blom HJ, Milos R, Goyette P, Shepparó CA, Matthews RG (1995). A candidate genetic risk factor for vascular disease: A commom mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
15. De Backer G, Ambrosioni E, Broch-Johnsen K et al (2003 European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Card Prev Reh 10:S1-S10
16. Gasparovic J, Raslova K, Basistova Z et al (2004). Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups. Physiol Res 53:215-218
17. Voetsch B, Damasceno BP, Camargo EC et al (2000) Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 83:229-233
18. Hanson NQ, Aras O, Yang F, Tsai MY (2001) C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: Incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47:661-666
19. Lonn E, Yusuf S, Phil D (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease. The Heart Outcomes Prevention Evaluation (HOPE). N Engl J Med 354:1567-1577
20. Bonaa KH, Njolstad I, Ueland PM et al (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. For the NORVIT Trial Investigators. N Engl J Med 354:1578-1588
21. Toole JF, Malinow MR, Chambless LE et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565-575
22. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM (2006) A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354:2764-2772
23. Stott DJ, MacIntosh G, Lowe GD et al (2005) Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 82:1320-1326
24. Jacobsen DW (1998) Homocysteine and vitamins in cardiovascular disease. Clin Chem 44:1833-1843
25. Morelli VM, Lourenco DM, D'Almeida V et al (2002) Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 13:271-275
26. Muniz MT, Siqueira ER, Fonseca RA et al (2006). Evaluation of MTHFR C677T gene polymorphism and homocysteine level in coronary atherosclerotic disease. Arq Bras Endocrinol Metabol 50:1059-1065
27. Garofolo L, Barros N Jr, Miranda F Jr, D'Almeida V, Cardien LC, Ferreira SR (2007) Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population. Eur J Vasc Endovasc Surg 34:23-28
28. Lima LM, Carvalho MG, Sabino AP et al (2006) Homocysteine and metilenetetrahydrofolate reductase (MTHFR) in subjects submitted to coronary angiography. Arq Bras Cardiol 88:167-172
29. Benchimol A, Bernard V, Pillois X, Hong NT, Benchimol D, Bonnet J (2004) Validation of a new method of detecting peripheral artery disease by determination of ankle-brachial index using an automatic blood pressure device. Angiology 55:127-134
30. Friedewald WT, Levy RI, Fredickison DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 18:449-452
31. Bozkurt A, Toyaksi H, Acartürk E, Tuli A, Cayli M (2003) The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease. Jpn Heart J 44:357-368
32. Malinow MR, Bostom AG, Krauss RM (1999) Homocysteine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99:178-182
33. Christen W, Ajani U, Glynn R (2000) Blood levels of homocysteine and increased risks of cardiovascular disease. Causal or casual? Arch Intern Med 169:422-434
34. de Paula SA, Ribeiro DD, Carvalho MG, Cardoso J, Dusse LM, Fernandes AP (2006) Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinolysis 17:271-275
35. Tavares EF, Vieira-Filho JP, Andriolo A et al (2004) Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: The relationship of homocysteine with other cardiovascular risk factors. Ethn Dis 14:49-56
36. Cappuccio FP, Bell R, Perry IJ et al (2002). Homocysteine levels in men and women of different ethnic and cultural background living in England. Atherosclerosis 164:95-102
37. Arruda VR, Siqueira LH, Goncalves MS et al. (1998). Prevalence of the mutation C677 T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335